Anti-Sm Ab (RDL)

Optimal Result: 0 - 20 Units.

Anti-Sm antibodies (Anti-Smith antibodies) are autoantibodies that are strongly associated with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The presence of Anti-Sm antibodies is considered a specific marker for SLE, as these antibodies are rarely found in individuals without the disease. It is reported that approximately 99% of individuals without SLE lack Anti-Sm antibodies, but they are present in only about 20% of people with SLE, indicating that while their presence is highly specific to SLE, they are not found in all cases of the disease.

The Anti-Smith antibody is known for its high specificity but low sensitivity for SLE. This means that while most people who test positive for Anti-Sm antibodies likely have SLE, not all SLE patients will test positive for these antibodies. In clinical practice, Anti-Sm antibody levels are elevated in about 30% of SLE cases and a smaller percentage (8%) of mixed connective tissue disease (MCTD) cases.

The clinical significance of Anti-Sm antibodies extends to the diagnosis and monitoring of SLE. They have been studied for their potential to predict lupus flares, which are periods when symptoms worsen dramatically. Research has compared the predictive value of Anti-Sm antibodies with that of anti-double-stranded DNA (anti-dsDNA) antibodies and complement assays, which are also used in monitoring SLE.

In terms of laboratory testing, evaluating for Anti-Sm antibodies is particularly useful for patients who show signs and symptoms of a connective tissue disease and have already tested positive for antinuclear antibodies (ANA). However, testing for Sm antibodies is not considered useful in patients without demonstrable ANAs. This is because ANAs are often the first indicator of an autoimmune condition, and the presence of Anti-Sm antibodies can provide additional specificity to the diagnosis.

If your Anti-Sm Ab (RDL) levels are within the normal reference range, it typically means that you do not have the antibodies that are commonly associated with systemic lupus erythematosus (SLE). Since these antibodies have high specificity for SLE, their absence suggests that it is less likely you have this autoimmune disease. However, it is important to note that not all patients with SLE will have detectable levels of Anti-Sm antibodies—only about 20% to 30% of SLE patients test positive for them.

A normal result for Anti-Sm antibodies might lead your healthcare provider to consider other diagnostic tests or look for other markers depending on your symptoms and clinical presentation. It's also possible to have SLE with a negative Anti-Sm antibody test, as SLE is diagnosed based on a combination of symptoms and laboratory results, not just one test alone. Therefore, if SLE is still suspected despite normal Anti-Sm levels, further testing for other autoantibodies, such as anti-double-stranded DNA (anti-dsDNA) or a complete panel of antinuclear antibodies (ANA), might be warranted to help in the diagnosis.

Additional note: If you have symptoms of a connective tissue disease or SLE, it's important to continue working with your healthcare provider to understand the full picture of your health, as lupus and related conditions can be complex and require a comprehensive evaluation.

What does it mean if your Anti-Sm Ab (RDL) result is too high?

If your Anti-Sm Ab (RDL) levels are above the reference range, it suggests the presence of Anti-Sm antibodies in your blood. Since Anti-Sm antibodies are highly specific for systemic lupus erythematosus (SLE), this result could be a strong indicator that you may have SLE, especially if you also have symptoms consistent with this autoimmune disease.

Elevated Anti-Sm antibody levels are not commonly found in healthy individuals or those with other diseases; however, a small percentage may be seen in patients with mixed connective tissue disease (MCTD). The presence of these antibodies is one of the criteria used for diagnosing SLE and can contribute to the overall clinical assessment.

The American College of Rheumatology includes Anti-Sm antibodies as one of the classification criteria for SLE, and their presence can carry weight in the diagnostic process. However, the diagnosis of SLE is typically made based on a combination of clinical findings and laboratory results, not just on the presence of Anti-Sm antibodies. Other factors, such as other autoantibody tests (like anti-dsDNA), complement levels, and the full range of signs and symptoms, are also important in making an accurate diagnosis.

Additional note: If you have elevated Anti-Sm antibody levels, your healthcare provider will likely conduct further assessments to confirm a diagnosis and to determine the most appropriate treatment plan. It is important to have a thorough discussion with your healthcare provider about what these results mean in the context of your overall health and symptoms.

10 000+ happy customers
100% satisfaction
★ ★ ★ ★ ★ customer support

Trust us to examine your lab results, guiding you towards improved health.

Use promo code to save 10% off any plan.

We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.